The positive and negative syndrome scale (PANSS) for schizophrenia
about
Exploring the psychosis functional connectome: aberrant intrinsic networks in schizophrenia and bipolar disorderCrowding deficits in the visual periphery of schizophrenia patientsSpeech graphs provide a quantitative measure of thought disorder in psychosisTemporal information processing in short- and long-term memory of patients with schizophreniaAutism spectrum disorders and schizophrenia: meta-analysis of the neural correlates of social cognitionDesign paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosisA long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophreniaDon't turn your back on the symptoms of psychosis: a proof-of-principle, quasi-experimental public health trial to reduce the duration of untreated psychosis in Birmingham, UKReduced crowding and poor contour detection in schizophrenia are consistent with weak surround inhibitionContextual social cognition impairments in schizophrenia and bipolar disorderAnatomical brain images alone can accurately diagnose chronic neuropsychiatric illnessesEarly interventions to prevent psychosis: systematic review and meta-analysisEarly intervention in patients at ultra high risk of psychosis: benefits and risksFacial emotion perception in schizophrenia: a meta-analytic reviewSingle photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjectsSelf management interventions for type 2 diabetes in adult people with severe mental illnessRisperidone (depot) for schizophreniaChlorpromazine versus atypical antipsychotic drugs for schizophreniaLithium for schizophreniaSupportive therapy for schizophreniaPyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesiaHaloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disordersClozapine for psychotic disorders in adults with intellectual disabilitiesPerphenazine for schizophreniaHIV prevention advice for people with serious mental illnessCompulsory community and involuntary outpatient treatment for people with severe mental disordersInterventions for obtaining and maintaining employment in adults with severe mental illness, a network meta-analysisAsenapine versus placebo for schizophreniaSelf-management interventions for type 2 diabetes in adult people with severe mental illnessCannabis and schizophreniaCarbamazepine for schizophreniaAtypical antipsychotics for psychosis in adolescentsBenzodiazepines for schizophreniaManagement of sexual dysfunction due to antipsychotic drug therapyPsychosocial interventions for people with both severe mental illness and substance misuseBenzodiazepines for psychosis-induced aggression or agitationGeneral physical health advice for people with serious mental illnessInformation and communication technology in patient education and support for people with schizophreniaSupported employment for adults with severe mental illnessHaloperidol versus first generation antipsychotics for schizophrenia
P2860
Q21129118-25EB855B-C5CB-47CE-82DA-C67D25A7DA0CQ21134028-A378C499-1B65-4E69-93C1-8D3AB829F1B0Q21134685-AFAE19F6-349D-43D0-B7F6-6A497482B1CEQ21134998-9C32E408-B06C-44F6-B594-81C6D34E5E1DQ21135009-E57195AA-E8A3-4910-89F3-A8C242CB772AQ21203727-D2C2F41C-6FE4-47A3-85D1-E3BAE3FAD9CEQ21260310-B150A37D-07F4-40E6-93EC-9955B585E330Q21260314-5ABE26DF-3A5C-4260-9C3F-B55D8C5C8A64Q21559665-E223294C-F157-4FCE-BEF5-0F472E7C331DQ21559683-8C02FF76-C78E-42E9-9AE4-112079D28D6EQ21559764-7E9045D9-DF44-4243-B2A6-645CC873713AQ22242061-AA87426B-744D-4C70-9211-71757B899350Q22242332-401E92E0-1833-4A43-B078-E2ADB68DB061Q22242828-78389CAA-CD5B-4842-92EB-27DA082C6D76Q22248075-89485330-E429-44EA-84C8-7E58C2F60044Q24185857-35D8153F-24F2-4768-B873-C8EFAF83E92BQ24185901-E6146FE3-C754-40DD-8FBC-095D1072755DQ24185922-43C8BE0F-99D1-4F36-9E51-5C37D50425C3Q24186325-D3E2A16F-8792-4809-BB07-0355A426FC96Q24186517-C4FBCF4A-8D71-47E4-BD50-BD3CE1D3F93DQ24186530-C595FB5B-B744-4382-B112-550663F54C15Q24186601-8771853F-2EA5-4D42-B438-DF1F5C99867BQ24187048-0AC9302C-A09B-4E37-9A10-BE7499EB0D35Q24187359-0CBCB8EA-7990-4DD7-BB9C-1DDEC2FFB0B0Q24187402-EF3021C7-53D8-44D6-B0DC-6F017DADD496Q24187441-1F360B7F-F06C-43CF-AD97-02B5137F9CD4Q24187558-084C9FDF-18F1-4CCC-B114-FF7A9B6B790EQ24187667-7F9B8CF3-9495-4063-A83E-F8F2CE1B340DQ24192950-77D72993-88F6-4F7D-930A-C8942D410259Q24193108-20FC61A0-B09E-48B7-9630-6DDC920E0F9EQ24194779-67A7C6F2-DEE6-490A-BA96-2F6921F84389Q24197475-563CF7F6-5001-494C-BBA2-1A3D67D02781Q24197501-9B95DEF1-0472-4CE8-A512-6E095C231D83Q24197558-AA06AA15-293D-43F5-B621-843C8D88E5A8Q24197576-6F237FA8-9AA6-48D3-90CD-9DBE582AA3E0Q24197734-3B6A1A3A-09DA-444A-948F-3284E2293C94Q24197831-076DD0E2-DECE-47EB-A294-2E237DC09E32Q24198042-E2893899-3448-4115-8D46-9474098B66EDQ24198083-435D36E0-0340-4BE3-802E-56C2A162BD12Q24198264-1A7D8659-EBF6-4672-A72F-32EEE1F2EF72
P2860
The positive and negative syndrome scale (PANSS) for schizophrenia
description
1987 nî lūn-bûn
@nan
1987 թուականին հրատարակուած գիտական յօդուած
@hyw
1987 թվականին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
The positive and negative syndrome scale (PANSS) for schizophrenia
@ast
The positive and negative syndrome scale (PANSS) for schizophrenia
@en
The positive and negative syndrome scale (PANSS) for schizophrenia
@nl
type
label
The positive and negative syndrome scale (PANSS) for schizophrenia
@ast
The positive and negative syndrome scale (PANSS) for schizophrenia
@en
The positive and negative syndrome scale (PANSS) for schizophrenia
@nl
prefLabel
The positive and negative syndrome scale (PANSS) for schizophrenia
@ast
The positive and negative syndrome scale (PANSS) for schizophrenia
@en
The positive and negative syndrome scale (PANSS) for schizophrenia
@nl
P2093
P3181
P356
P1476
The positive and negative syndrome scale (PANSS) for schizophrenia
@en
P2093
P304
P3181
P356
10.1093/SCHBUL/13.2.261
P407
P577
1987-01-01T00:00:00Z